+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood Disease Drugs Markets in China

  • PDF Icon

    Report

  • 290 Pages
  • November 2023
  • Region: China
  • AMID Co
  • ID: 1022810

China's demand for Blood Disease Drugs will continue to grow at 10% by 2032

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and the in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

This market research report provides hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, this research report provides the insights and projections into Chinese markets necessary for you to do so.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
  • Blood Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
  • Overview
  • Demand of Blood Disease Drugs by Region
  • Blood Disease Drugs Sales Volume
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Sales Volume
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Imports
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs Imports
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Imports
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Imports
  • Pricing Trends
V. BLOOD DISEASE DRUGS MARKET OUTLOOK
  • Blood Disease Drugs Market Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
VI. MARKETING STRATEGIES
  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China’s Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises
VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY
  • Blood Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations
ULIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
II. BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Location
  • Major Blood Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
  • Total Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Major Producer and Their Market Share
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Anemia Treatment Drugs Major Producer and Their Market Share
  • Mecobalamin Major Producer and Their Market Share
  • Cobamamide Major Producer and Their Market Share
  • Ferrous Succinate Major Producer and Their Market Share
  • Leucogen Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Major Producer and Their Market Share
  • Batilol Major Producer and Their Market Share
  • Inosine Major Producer and Their Market Share
  • Deoxyribonucleotide Major Producer and Their Market Share
  • Adrenocortical Hormone Major Producer and Their Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
  • Leukemia Treatment Drugs Major Producer and Their Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Major Producers and Their Market Share
  • Imatinib Mesylate Major Producer and Their Market Share
  • Rituximab Major Producer and Their Market Share
  • Pirarubicin Major Producer and Their Market Share
  • Hydroxycampothecin Major Producer and Their Market Share
  • Blood Disease Drugs Import
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • Leukemia Treatment Drugs Import Volume by Drugs Classification
V. BLOOD DISEASE DRUGS MARKET OUTLOOK
  • Consumer Spending Trend
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
ULIST OF CHARTS
I. NTRODUCTION
  • Blood Disease Drugs Sales Volume
II. BUSINESS ENVIRONMENT
  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China’s Imports and Exports
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
  • Blood Disease Drugs Sales Volume
  • Worldwide Blood Disease Drugs Demand by region
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Mecobalamin Sales Volume and Market Share
  • Cobamamide Sales Volume and Market Share
  • Ferrous Succinate Sales Volume and Market Share
  • Leucogen Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Sales Volume and Market Share
  • Batilol Sales Volume and Market Share
  • Inosine Sales Volume and Market Share
  • Deoxyribonucleotide Sales Volume and Market Share
  • Adrenocortical Hormone Sales Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Sales Volume and Market Share
  • Imatinib Mesylate Sales Volume and Market Share
  • Rituximab Sales Volume and Market Share
  • Pirarubicin Sales Volume and Market Share
  • Hydroxycampothecin Sales Volume and Market Share
  • Other Blood Disease Drugs Sales volume and Market Share
  • Blood Disease Drugs Import Volume
  • Anemia Import Volume and Market Share
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Mecobalamin Import Volume and Market Share
  • Cobamamide Import Volume and Market Share
  • Ferrous Succinate Import Volume and Market Share
  • Leucogen Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • VitamineB4 Import Volume and Market Share
  • Batilol Import Volume and Market Share
  • Inosine Import Volume and Market Share
  • Deoxyribonucleotide Import Volume and Market Share
  • Adrenocortical Hormone Import Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume by Drugs Classification
  • Interferon Treatment Drugs Import Volume and Market Share
  • Imatinib Mesylate Treatment Drugs Import Volume and Market Share
  • Rituximab Treatment Drugs Import Volume and Market Share
  • Pirarubicin Treatment Drugs Import Volume and Market Share
  • Hydroxycampothecin Treatment Drugs Import Volume and Market Share
  • Other Blood Disease Drugs Import Volume and Market Share
VI. MARKETING STRATEGIES
  • China’s Distribution Channel

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • North China Pharmaceutical Group Co., Ltd
  • Chongqing Yaoyou Pharmaceutical Co., Ltd